Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-297419
Filing Date
2011-11-04
Accepted
2011-11-04 16:21:41
Documents
9
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d251539d10q.htm 10-Q 480181
2 CERTIFICATION PURSUANT TO SECTION 302 d251539dex311.htm EX-31.1 10398
3 CERTIFICATION PURSUANT TO SECTION 302 d251539dex312.htm EX-31.2 10965
4 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 d251539dex321.htm EX-32.1 6151
  Complete submission text file 0001193125-11-297419.txt   1586476

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rdea-20110930.xml EX-101.INS 165942
6 XBRL TAXONOMY EXTENSION SCHEMA rdea-20110930.xsd EX-101.SCH 7816
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rdea-20110930_cal.xml EX-101.CAL 29182
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rdea-20110930_lab.xml EX-101.LAB 98482
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rdea-20110930_pre.xml EX-101.PRE 58763
Mailing Address 4939 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4939 DIRECTORS PLACE SAN DIEGO CA 92121 858-652-6500
Ardea Biosciences, Inc./DE (Filer) CIK: 0001103390 (see all company filings)

EIN.: 943200380 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33734 | Film No.: 111181390
SIC: 2834 Pharmaceutical Preparations